FINWIRES · TerminalLIVE
FINWIRES

SKハイニックス、第1四半期の利益が398%急増、売上高は50兆ウォンの大台を突破

-- SKハイニックス(KRX:000660)は、韓国取引所への木曜日の提出書類によると、第1四半期の帰属利益が前年同期の8兆1070億ウォンから398%増の40兆3000億ウォンに急増した。 同社の売上高は前年同期の17兆6000億ウォンから198%増の52兆6000億ウォンに急増した。 売上高で世界第3位の半導体メーカーである同社は、四半期ベースで初めて売上高が50兆ウォンを突破したと、木曜日のプレスリリースで発表した。 営業利益は前年同期の7兆4410億ウォンから405%増の過去最高となる37兆6000億ウォンに増加した。 同社の営業利益率は前年同期の42%から72%に拡大した。 SKハイニックスは、2026年第1四半期も人工知能(AI)インフラ投資の拡大により堅調な需要が続いたと発表しました。 また、同四半期の成長は、高帯域幅メモリ、大容量サーバー向けDRAMモジュール、エンタープライズ向けeSSDの販売増によるものだとしています。 現金および現金同等物は19兆4,000億ウォン増加し54兆3,000億ウォンとなった一方、有利子負債は前四半期比2兆9,000億ウォン減少し19兆3,000億ウォンとなりました。 SKハイニックスは、多様化するメモリ需要に対応するため、DRAMおよびNANDフラッシュ分野で新製品を投入する計画だと述べています。 さらに、「メモリ効率化技術の普及はAIサービスの経済的実現可能性を高め、サービス全体の規模拡大につながり、メモリ需要をさらに押し上げるだろう」と、同社は決算発表で述べています。 半導体メーカーは2026年に設備投資を「大幅に」拡大する計画であり、将来的に「過剰」な生産量を生み出す可能性はあるものの、2027年半ばまでは製造能力をほとんど増強しないだろうと、バロンズ誌は木曜日に報じた。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB